Cart
sales@molnova.com
VU-WS113
CAS No. 1415921-09-3
VU-WS113( VU-WS 113 )
Catalog No. M11731 CAS No. 1415921-09-3
VU-WS113 is a potent inhibitor of Wnt signaling with EC50 of 80 nM that selectively potentiates CK1α kinase activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVU-WS113
-
NoteResearch use only, not for human use.
-
Brief DescriptionVU-WS113 is a potent inhibitor of Wnt signaling with EC50 of 80 nM that selectively potentiates CK1α kinase activity.
-
DescriptionVU-WS113 is a potent inhibitor of Wnt signaling with EC50 of 80 nM that selectively potentiates CK1α kinase activity.
-
In Vitro——
-
In Vivo——
-
SynonymsVU-WS 113
-
PathwayMetabolic Enzyme/Protease
-
TargetCasein Kinase
-
RecptorCasein Kinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1415921-09-3
-
Formula Weight440.54
-
Molecular FormulaC27H28N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=CC(=C(N1C2=CC=CC=C2)C)C(=O)NC3=NC4=C(C=C3)C=C(C=C4)CN5CCOCC5
-
Chemical Name2,5-dimethyl-N-[6-(morpholin-4-ylmethyl)quinolin-2-yl]-1-phenylpyrrole-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Thorne CA, et al. Nat Chem Biol. 2010 Nov;6(11):829-36.
molnova catalog
related products
-
TTP 22
TTP 22 is a high affinity, ATP-competitive casein kinase 2 (CK2) inhibitor with IC50/Ki of 0.1 uM/40 nM.
-
A-3 hydrochloride
A-3 hydrochloride is a potent, cell-permeable, reversible, ATP-competitive non-selective antagonist of various kinases. A-3 hydrochloride also inhibits PKC and casein kinase I with Ki values of 47 μM and 80 μM, respectively[1]. A-3 hydrochloride against PKA (Ki=4.3 μM), casein kinase II (Ki=5.1 μM) and myosin light chain kinase (MLCK) (Ki=7.4 μM).
-
Casein Kinase inhibi...
Casein Kinase inhibitor A86 (CKIα inhibitor A86) is a novel pan-specific CKI (CSNK1) inhibitor.
